Topics

Mylan and Upjohn Delay Close of Merger Due to COVID-19 Pandemic

20:00 EDT 25 Mar 2020 | BioSpace

The delays, particularly in the regulatory review process, have caused the merger completion to be pushed back to the second half of this year.

Original Article: Mylan and Upjohn Delay Close of Merger Due to COVID-19 Pandemic

NEXT ARTICLE

More From BioPortfolio on "Mylan and Upjohn Delay Close of Merger Due to COVID-19 Pandemic"

Quick Search

Relevant Topic

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...